{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T19:52:41Z","timestamp":1775677961556,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.prp.2017.12.003","type":"journal-article","created":{"date-parts":[[2017,12,8]],"date-time":"2017-12-08T11:49:47Z","timestamp":1512733787000},"page":"181-186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Expression profiles of Annexin A1, formylated peptide receptors and cyclooxigenase-2 in gastroesophageal inflammations and neoplasias"],"prefix":"10.1016","volume":"214","author":[{"given":"Rodolfo T.C.","family":"Takaoka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nath\u00e1lia D.","family":"Sert\u00f3rio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lara P.J.","family":"Magalini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leandro M.","family":"Dos Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena R.","family":"Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melina M.","family":"Iyomasa-Pilon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas","family":"Possebon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara S.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana P.","family":"Girol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.prp.2017.12.003_bib0005","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3322\/caac.21149","article-title":"Cancer treatment and survivorship statistic, 2012","volume":"62","author":"Siegel","year":"2012","journal-title":"CA. Cancer J. Clin."},{"issue":"2","key":"10.1016\/j.prp.2017.12.003_bib0010","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistic","volume":"61","author":"Jemal","year":"2011","journal-title":"CA. Cancer J. Clin."},{"issue":"4","key":"10.1016\/j.prp.2017.12.003_bib0015","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1007\/s13187-015-0818-z","article-title":"The development of a communication tool to facilitate the cancer trial recruitment process and increase research literacy among underrepresented populations","volume":"30","author":"Torres","year":"2015","journal-title":"J. Cancer Educ."},{"issue":"1","key":"10.1016\/j.prp.2017.12.003_bib0020","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ccr.2008.06.010","article-title":"Inflaming gastrointestinal oncogenic programming","volume":"14","author":"DeNardo","year":"2008","journal-title":"Cancer Cell."},{"issue":"12","key":"10.1016\/j.prp.2017.12.003_bib0025","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1158\/1940-6207.CAPR-16-0209","article-title":"Targeting inflammation in cancer prevention and terapy","volume":"9","author":"Todoric","year":"2016","journal-title":"Cacer Prev. Res. (Phila)"},{"issue":"3","key":"10.1016\/j.prp.2017.12.003_bib0030","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0016-5085(00)70254-X","article-title":"Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: ex vivo induction by bile salts and acid exposure","volume":"118","author":"Shirvani","year":"2000","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.prp.2017.12.003_bib0035","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1053\/gast.2002.33580","article-title":"Prognostic significance of elevated cyclooxygenase 2 expression in patients with adenocarcinoma of the esophagus","volume":"122","author":"Buskens","year":"2002","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.prp.2017.12.003_bib0040","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1442-2050.2004.00390.x","article-title":"Cyclo-oxygenase-2 expression in esophageal adenocarcinoma as a determinant of clinical outcome following esophagectomy","volume":"17","author":"France","year":"2004","journal-title":"Dis. Esophagus"},{"issue":"75","key":"10.1016\/j.prp.2017.12.003_bib0045","first-page":"758","article-title":"Clinicopathologic significance of expression of cyclooxygenase-2 in human esophageal squamous cell carcinoma","volume":"54","author":"Hashimoto","year":"2007","journal-title":"Hepatogastroenterology"},{"issue":"10","key":"10.1016\/j.prp.2017.12.003_bib0050","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1002\/1097-0142(20010515)91:10<1876::AID-CNCR1209>3.0.CO;2-H","article-title":"Depth of invasion parallels increased cyclooxygenase-2 levels in patients with gastric carcinoma","volume":"91","author":"Ohno","year":"2001","journal-title":"Cancer"},{"issue":"19","key":"10.1016\/j.prp.2017.12.003_bib0055","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.3748\/wjg.v10.i19.2809","article-title":"Roles of Helicobacter pylori infection and cyclooxygenase-2 expression in gastric carcinogenesis","volume":"10","author":"Sun","year":"2004","journal-title":"World J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.prp.2017.12.003_bib0060","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jnci.2016.05.005","article-title":"Expression of cyclooxygenase 2 and vascular endothelial growth factor in gastric carcinoma: relationship with clinicopathological parameters","volume":"28","author":"Hafez","year":"2016","journal-title":"J. Egypt Natl. Canc. Inst."},{"issue":"2","key":"10.1016\/j.prp.2017.12.003_bib0065","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3892\/ol.2016.5506","article-title":"From inflammation to gastric cancer: role of Helicobacter pylori","volume":"13","author":"Zhang","year":"2017","journal-title":"Oncol Lett."},{"issue":"1","key":"10.1016\/j.prp.2017.12.003_bib0070","first-page":"135","article-title":"Cyclooxygenase-2 expression is related to prostaglandin biosynthesis and angiogenesis in human gastric cancer","volume":"6","author":"Uefuji","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2017.12.003_bib0075","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1186\/1471-2407-14-520","article-title":"Differential expression of ANXA1 in benign human gastrointestinal tissues and cancers","volume":"14","author":"Gao","year":"2014","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.prp.2017.12.003_bib0080","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1096\/fj.06-7464rev","article-title":"Annexin 1: the new face of an old molecule","volume":"21","author":"Lim","year":"2007","journal-title":"FASEB J."},{"issue":"11","key":"10.1016\/j.prp.2017.12.003_bib0085","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.2217\/fon.13.114","article-title":"Potential role of Anxa1 in cancer","volume":"9","author":"Guo","year":"2013","journal-title":"Future Oncol."},{"issue":"30","key":"10.1016\/j.prp.2017.12.003_bib0090","doi-asserted-by":"crossref","first-page":"6829","DOI":"10.3748\/wjg.v22.i30.6829","article-title":"Molecular mechanisms of peritoneal dissemination in gastric cancer","volume":"22","author":"Kanda","year":"2016","journal-title":"World J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.prp.2017.12.003_bib0095","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1042\/CS20150415","article-title":"Annexin A1 localization and its relevance to cancer","volume":"130","author":"Boudharaa","year":"2016","journal-title":"Clin. Sci. (Lond.)"},{"issue":"22","key":"10.1016\/j.prp.2017.12.003_bib0100","first-page":"6293","article-title":"Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma","volume":"60","author":"Pawaletz","year":"2000","journal-title":"Cancer Res."},{"issue":"43","key":"10.1016\/j.prp.2017.12.003_bib0105","doi-asserted-by":"crossref","first-page":"6641","DOI":"10.1038\/sj.onc.1205818","article-title":"Three isoforms of annexin I are preferentially expressed in normal esophageal epithelia but down-regulated in esophageal squamous cell carcinomas","volume":"21","author":"Xia","year":"2002","journal-title":"Oncogene"},{"issue":"18 Pt 1","key":"10.1016\/j.prp.2017.12.003_bib0110","doi-asserted-by":"crossref","first-page":"6013","DOI":"10.1158\/1078-0432.CCR-04-0317","article-title":"Comprehensive characterization of annexin I alterations in esophageal squamous cell carcinoma","volume":"10","author":"Hu","year":"2004","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.prp.2017.12.003_bib0115","doi-asserted-by":"crossref","first-page":"G764","DOI":"10.1152\/ajpgi.00531.2007","article-title":"Annexin-1 modulates repair of gastric mucosal injury","volume":"294","author":"Martin","year":"2008","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"2","key":"10.1016\/j.prp.2017.12.003_bib0120","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3892\/etm.2011.210","article-title":"Up-regulated Annexin A1 expression in gastrointestinal cancer is associated with cancer invasion and lymph node metastasis","volume":"2","author":"Sato","year":"2011","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.prp.2017.12.003_bib0125","doi-asserted-by":"crossref","first-page":"152860","DOI":"10.1155\/2013\/152860","article-title":"Expression of annexin-A1 and galectin-1 anti-inflammatory proteins and mRNA in chronic gastritis and gastric cancer","volume":"2013","author":"Jorge","year":"2013","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.prp.2017.12.003_bib0130","doi-asserted-by":"crossref","first-page":"478138","DOI":"10.1155\/2014\/478138","article-title":"Deregulation of annexin-A1 and galectin-1 expression in precancerous gastric lesions: intestinal metaplasia and gastric ulcer","volume":"2014","author":"Rossi","year":"2014","journal-title":"Mediators Inflamm."},{"issue":"2","key":"10.1016\/j.prp.2017.12.003_bib0135","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/path.2400","article-title":"The role of annexins in tumour development and progression","volume":"216","author":"Mussunoor","year":"2008","journal-title":"J. Pathol."},{"issue":"23","key":"10.1016\/j.prp.2017.12.003_bib0140","doi-asserted-by":"crossref","first-page":"5757","DOI":"10.1002\/cncr.27565","article-title":"Annexin A1 is associated with gastric cancer survival and promotes gastric cancer cell invasiveness through the formyl peptide receptor\/extracellular signal-regulated kinase\/integrin beta-1-binding protein 1 pathway","volume":"118","author":"Cheng","year":"2012","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.prp.2017.12.003_bib0145","first-page":"2223","article-title":"Formyl Peptide receptor 1 expression is associated with tumor progression and survival in gastric cancer","volume":"34","author":"Cheng","year":"2014","journal-title":"Anticancer Res."},{"issue":"52","key":"10.1016\/j.prp.2017.12.003_bib0150","doi-asserted-by":"crossref","first-page":"6667","DOI":"10.1038\/onc.2008.256","article-title":"MicroRNA-196a targets annexin A1: a microRNA-mediated mechanism of annexin A1 downregulation in cancers","volume":"27","author":"Luthra","year":"2008","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.prp.2017.12.003_bib0155","doi-asserted-by":"crossref","first-page":"e39244","DOI":"10.1371\/journal.pone.0039244","article-title":"Up-regulation of Annexin-A1 and lipoxin A(4) in individuals with ulcerative colitis may promote mucosal homeostasis","volume":"7","author":"Vong","year":"2012","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.prp.2017.12.003_bib0160","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1080\/14728222.2017.1364363","article-title":"A1 and specialized proresolving lipid mediators: promoting resolution as a therapeutic strategy in human inflammatory diseases","volume":"21","author":"Perucci","year":"2017","journal-title":"Expert Opin. Ther. Targets"},{"issue":"8","key":"10.1016\/j.prp.2017.12.003_bib0165","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/j.1365-2036.2011.04801.x","article-title":"Distinct proteomic profiles characterise non-erosive from erosive reflux disease","volume":"34","author":"Calabrese","year":"2011","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.prp.2017.12.003_bib0170","first-page":"751","article-title":"Association of nuclear annexin A1 with prognosis of patients with esophageal squamous cell carcinoma","volume":"7","author":"Hang","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"15","key":"10.1016\/j.prp.2017.12.003_bib0175","doi-asserted-by":"crossref","first-page":"4598","DOI":"10.1158\/1078-0432.CCR-06-0483","article-title":"Expression of annexin A1 in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome","volume":"12","author":"Wang","year":"2006","journal-title":"Clin. Cancer Res."},{"issue":"43","key":"10.1016\/j.prp.2017.12.003_bib0180","doi-asserted-by":"crossref","first-page":"7795","DOI":"10.3748\/wjg.v19.i43.7795","article-title":"Identification of Annexin A1 protein expression in human gastric adenocarcinoma using proteomics and tissue microarray","volume":"19","author":"Zhang","year":"2013","journal-title":"World J. Gastroenterol."},{"issue":"7","key":"10.1016\/j.prp.2017.12.003_bib0185","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s10585-008-9178-y","article-title":"Tissue microarray analysis reveals strong clinical evidence for a close association between loss of annexin A1 expression and nodal metastasis in gastric cancer","volume":"25","author":"Yu","year":"2008","journal-title":"Clin. Exp. Metastasis"},{"issue":"2","key":"10.1016\/j.prp.2017.12.003_bib0190","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.3390\/ijms14022652","article-title":"Annexin-phospholipid interactions. functional implications","volume":"14","author":"Lizarbe","year":"2013","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.prp.2017.12.003_bib0195","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000074421","article-title":"Expression of cyclooxygenase-1 and cyclooxygenase-2 in human esophageal mucosa, dysplasia and carcinoma","volume":"71","author":"Kase","year":"2004","journal-title":"Pathobiology"},{"issue":"4","key":"10.1016\/j.prp.2017.12.003_bib0200","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1053\/gast.2002.32371","article-title":"Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus","volume":"122","author":"Buttar","year":"2002","journal-title":"Gastroenterology"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033817310634?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033817310634?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T08:24:43Z","timestamp":1540455883000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033817310634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0344033817310634"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2017.12.003","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression profiles of Annexin A1, formylated peptide receptors and cyclooxigenase-2 in gastroesophageal inflammations and neoplasias","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2017.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}